Literature DB >> 8835751

Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related.

L van Obbergh1, Y Vallieres, G Blaise.   

Abstract

BACKGROUND/AIMS: Although the cardiac output is increased in liver cirrhosis, some degree of cardiac failure could coexist as suggested by human investigations showing cardiac enlargement in cirrhosis and by animal studies describing a limited response to fluid loading in the cirrhotic rat. Endotoxemia induces similar hemodynamic changes during the septic shock. This septic cardiomyopathy has been attributed to an increased secretion of nitric oxide by the myocytes. In this study, we aimed to verify if cirrhotic cardiomyopathy was present in the rat with biliary cirrhosis, and if it could be related to abnormal nitric oxide secretion.
METHODS: We therefore compared the coronary pressure, the systolic ventricular pressure and the peak rate of rise of the left ventricular pressure obtained from isolated hearts perfused with a modified Langendorff apparatus in control rats and in cirrhotic rats obtained by bile duct ligation. The variations occurring after inhibition of nitric oxide synthesis by the addition of NG monomethyl-L-arginine (10(-6)M) to the perfusing Krebs-Ringer solution were also studied in both groups.
RESULTS: We found that the coronary pressure and the contractility of the cirrhotic hearts decreased significantly when compared to the controls. Inhibition of the nitric oxide synthesis increased those values significantly when the hearts were obtained from cirrhotic animals. This was not observed in the control group.
CONCLUSIONS: Our data suggest that the cardiac modifications induced by the cirrhosis in the studied parameters are related to nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835751     DOI: 10.1016/s0168-8278(96)80272-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  16 in total

Review 1.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

Review 2.  Cirrhotic cardiomyopathy: a cardiologist's perspective.

Authors:  Natig Gassanov; Evren Caglayan; Nasser Semmo; Gero Massenkeil; Fikret Er
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

3.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

4.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors:  J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

5.  Dilated cardiomyopathy and progressive familial intrahepatic cholestasis.

Authors:  Stephanie James; Deirdre Waterhouse; Kenneth McDonald; Rory O'Hanlon
Journal:  BMJ Case Rep       Date:  2014-03-20

6.  High Flow-Mediated Vasodilatation Predicts Pulmonary Edema in Liver Transplant Patients.

Authors:  Shyh-Ming Chen; Chao-Long Chen; Han-Tan Chai; Chee-Chien Yong; Hsien-Wen Hsu; Yu-Fan Cheng; Morgan Fu; Yu-Tung Anton Huang; Chi-Ling Hang
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

7.  Septic cardiomyopathy - A not yet discovered cardiomyopathy?

Authors:  Ursula Muller-Werdan; Michael Buerke; Henning Ebelt; Konstantin M Heinroth; Anja Herklotz; Harald Loppnow; Martin Ruß; Frithjof Schlegel; Axel Schlitt; Hendrik B Schmidt; Gerold Söffker; Karl Werdan
Journal:  Exp Clin Cardiol       Date:  2006

Review 8.  Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.

Authors:  HongQun Liu; Seyed Ali Gaskari; Samuel S Lee
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

9.  Cirrhotic cardiomyopathy: review of pathophysiology and treatment.

Authors:  Maneerat Chayanupatkul; Suthat Liangpunsakul
Journal:  Hepatol Int       Date:  2014-07       Impact factor: 6.047

Review 10.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.